\n\n\n\n\t\t\n\t\t\tSanarus Medical\n\t\t\thttp://www.sanarus.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tSanarus Medical is dedicated to advancing women\'s health by providing minimally invasive products for the diagnosis and treatment of breast tumors. The Sanarus cryoablation technology enables a cost...More»
\n\t\t\tSanarus Medical is dedicated to advancing women\'s health by providing minimally invasive products for the diagnosis and treatment of breast tumors. The Sanarus cryoablation technology enables a cost effective, office based procedure, which provides an important alternative to women that currently have to undergo an operating room based, surgically intensive procedure. Sanarus is in early commercialization of its products, including the Visica (TM) Treatment System, for use in the ablation of breast fibroadenomas. Before the Visica Treatment System came on the market the only option for women was open surgical removal. Now these women can choose the Visica minimally invasive office procedure, which accomplishes what the open surgical procedure does without the added complications, scarring and recovery time.«Less
\n\n\t\t\tOverview
\n\t\t\t\tLocation: \tPleasanton, CA, United States\n
\n\t\t\t\tIndustry: Biopharmaceuticals
\n\t\t\t\tTags:\n\t\t\t\tmedical,\n\t\t\t\tbreast care,\n\t\t\t\tcancer,\n\t\t\t\tSanarus,\n\t\t\t\tcryoablation,\n\t\t\t\tVisica,\n\t\t\t\tbreast,\n\t\t\t\tsurgery,\n\t\t\t\tbreat fibroadenomas,\n\t\t\t\tdiagnostic\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series E - $15M (02/20/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tAlta Partners,\n\t\t\t\t\t\n\t\tCapital Valley Ventures,\n\t\t\t\t\t\n\t\tChannel Medical Partners,\n\t\t\t\t\t\n\t\tEaston Capital Partners,\n\t\t\t\t\t\n\t\tFederated Kaufmann Fund,\n\t\t\t\t\t\n\t\tForward Ventures,\n\t\t\t\t\t\n\t\tMosaix Venture,\n\t\t\t\t\t\n\t\tPequot Ventures,\n\t\t\t\t\t\n\t\tTechnology Funding,\n\t\t\t\t\t\n\t\tU.S. Venture Partners\n\t\t\t\t
\n\t\t\tMarket
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tDiamics,\n\t\t\t\t\tOn-Q-Ity,\n\t\t\t\t\tVarian Medical Systems,\n\t\t\t\t\tStryker Endoscopy,\n\t\t\t\t\tVantage Oncology,\n\t\t\t\t\tNuvelo,\n\t\t\t\t\tChromoTrax,\n\t\t\t\t\tRedPath Integrated Pathology\n\t\t\t\t
\n\t\t\t